To mark Parkinson's Awareness Month 2020, RCSI are hosting an event about the state-of-the-art Parkinson's research in Ireland. Perspectives from research laboratories, the clinic, industry and those with the condition will be shared through short, lively talks followed by a Q&A session. Talks will be followed by a reception and an introduction to set dancing for Parkinson's. Anyone with an interest in Parkinson’s is invited to attend, including students, researchers, people with the condition, carers, health professionals and patient advocacy groups! Date: Wednesday, 1st April 2020 Time: 5:30 pm-9 pm Location: RCSI, 123 St. Stephen’s Green, Dublin Confirmed speakers to date include: Parkinson's Association of Ireland, Gary Boyle NUI Galway, Eilis Dowd, Leo Quinlan, Parkinson's researchers RCSI, Jochen Prehn, PD-MitoQUANT Project Coordinator UCC, TBC, Parkinson's researcher Inflazome, TBC, Industry representative We are delighted to be able to offer travel bursaries of €100 euro to attend this event. Interested attendees should apply with a short [...]
Happy New Year to all who are following the progress of PD-MitoQUANT. We are pleased to provide you with our latest project update. Please find our January 2020 newsletter for download here.
Congratulations to all authors involved in the latest PD-MitoQUANT-acknowledged publication: Nolwen L. Rey, Luc Bousset, Sonia George, Zachary Madaj, Lindsay Meyerdirk, Emily Schulz, Jennifer A. Steiner, Ronald Melki and Patrik Brundin. PD-MitoQUANT PIs Luc Bousset and Ronald Melki are researchers at the Centre National de la Recherche Scientifique (CNRS). The open access paper entitled: α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb appears in Acta Neuropathologica Communications (2019) 7:221. The study was published on the 30th of December 2019. Read the paper here.
Olga Corti, PhD is a Research Director at the Institut du Cerveau et de la Moelle épinière (ICM) located in Paris, France. Olga is an expert in the functional analysis of protein products of Parkinson’s genes with a focus on mechanisms of mitochondrial quality control. We asked Olga some questions about her research and ICM’s role within PD-MitoQUANT. Within Parkinson’s research, which cell types and mechanisms are most interesting to you at the moment and why? Parkinson’s disease (PD) is due to the gradual loss of specific neuronal populations, particularly those that produce the neurotransmitter dopamine in a deep structure of the brain called substantia nigra. We still do not understand why these neurons die, and it is essential that we do so if we want to find out how to prevent this degenerative process. Until recently, scientists have only been able to study these neurons post mortem, on brains [...]
PD-MitoQUANT PIs organise “pHysiopathology of Parkinson’s DisEase” (HOPE) 2020 conference at ICM, Paris
PD-MitoQUANT PIs Drs. Olga Corti, Stéphane Hunot (both based at the ICM) and Luc Bousset (Centre National de la Recherche Scientifique (CNRS)) are on the organizing committee of the 2nd "pHysiopathology of Parkinson's DisEase" (HOPE) conference taking place at the Institut du Cerveau et de la Moelle Epinière (ICM) in Paris from the 29th -31st January 2020. Following the success of the first edition and the positive feedback from participants regarding the latest scientific advances and the integration of basic research into clinical research, ICM is pleased to invite researchers to take part in this second edition. Topics include the epigenetic and genetic determinants of Parkinson's disease, their molecular mechanisms and their modelling, in order to better understand the pathophysiology of Parkinson's disease and open pre-clinical, clinical and imaging perspectives. In addition, ICM proposes a workshop the first day on two topics that will be discussed during the congress: "Cellular modelling using microfluidic and stem [...]